Annual Congress Berlin 2008

---

---

PG6 - Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer)

Postgraduate Course
Chairs: A.-P. Meert (Brussels, Belgium), R. M. Huber (Munich, Germany)
Aims: This is the third course in a three-year postgraduate core curriculum devoted to thoracic oncology. Participants can attend a single module and earlier modules in the series can be viewed on the ERS e-learning resources. This last course focuses on innovative treatments for thoracic malignancies other than nonsmall cell lung cancer.
The specific aims of this last module in the series are:
-to review the current knowledge on the optimal integration of systemic and local treatments for small cell lung cancer;
-to review the approach to mediastinal tumours;
-to summarise the current treatment of mesothelioma;
-to address issues in supportive care, including anti-emetics, growth factors and symptomatic treatments.

Systemic treatment of small cell lung cancer E. Quoix (Strasbourg, France)
Optimal integration of chemo- and radiotherapy in small cell lung cancer D. De Ruysscher (Maastricht, The Netherlands)
Mediastinal tumors H. Ris (Lausanne, Switzerland)
Mesothelioma A. Scherpereel (Lille, France)
Supportive care and local palliation for thoracic malignancies R. M. Huber (Munich, Germany)